|Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non–small cell lung cancer|
PC Ma, R Jagadeeswaran, S Jagadeesh, MS Tretiakova, V Nallasura, ...
Cancer research 65 (4), 1479-1488, 2005
|Expression and mutational analysis of MET in human solid cancers|
PC Ma, MS Tretiakova, AC MacKinnon, N Ramnath, C Johnson, ...
Genes, Chromosomes and Cancer 47 (12), 1025-1037, 2008
|The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma|
TY Seiwert, R Jagadeeswaran, L Faoro, V Janamanchi, V Nallasura, ...
Cancer research 69 (7), 3021-3031, 2009
|Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma|
R Jagadeeswaran, PC Ma, TY Seiwert, S Jagadeeswaran, O Zumba, ...
Cancer research 66 (1), 352-361, 2006
|Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion|
PC Ma, MS Tretiakova, V Nallasura, R Jagadeeswaran, AN Husain, ...
British journal of cancer 97 (3), 368-377, 2007
|c-Met is a potentially new therapeutic target for treatment of human melanoma|
N Puri, S Ahmed, V Janamanchi, M Tretiakova, O Zumba, T Krausz, ...
Clinical cancer research 13 (7), 2246-2253, 2007
|A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts|
N Puri, A Khramtsov, S Ahmed, V Nallasura, JT Hetzel, R Jagadeeswaran, ...
Cancer research 67 (8), 3529-3534, 2007
|Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion|
R Jagadeeswaran, H Surawska, S Krishnaswamy, V Janamanchi, ...
Cancer research 68 (1), 132-142, 2008
|FYN is overexpressed in human prostate cancer|
EM Posadas, H Al‐Ahmadie, VL Robinson, R Jagadeeswaran, K Otto, ...
BJU international 103 (2), 171-177, 2009
|In vitro studies on the selective cytotoxic effect of crocetin and quercetin|
R Jagadeeswaran, C Thirunavukkarasu, P Gunasekaran, N Ramamurty, ...
Fitoterapia 71 (4), 395-399, 2000
|Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition|
J Yang, MA Price, GY Li, M Bar-Eli, R Salgia, R Jagedeeswaran, ...
Cancer research 69 (19), 7538-7547, 2009
|Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model|
K MohanKumar, N Kaza, R Jagadeeswaran, SA Garzon, A Bansal, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 303 (1 …, 2012
|Receptor tyrosine kinases and inhibitors in lung cancer|
E Pisick, S Jagadeesh, R Salgia
TheScientificWorldJOURNAL 4, 589-604, 2004
|Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells|
R Jagadeeswaran, S Jagadeeswaran, VP Bindokas, R Salgia
American Journal of Physiology-Lung Cellular and Molecular Physiology 292 (6 …, 2007
|Nucleophosmin interacts with FOXM1 and modulates the level and localization of FOXM1 in human cancer cells|
UG Bhat, R Jagadeeswaran, M Halasi, AL Gartel
Journal of Biological Chemistry 286 (48), 41425-41433, 2011
|Smad7 inhibits autocrine expression of TGF-β2 in intestinal epithelial cells in baboon necrotizing enterocolitis|
K Namachivayam, CL Blanco, K MohanKumar, R Jagadeeswaran, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 304 (2 …, 2013
|The LSD1 inhibitor RN-1 recapitulates the fetal pattern of hemoglobin synthesis in baboons (P. anubis)|
A Rivers, K Vaitkus, V Ibanez, MA Ruiz, R Jagadeeswaran, ...
Haematologica 101 (6), 688, 2016
|C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes|
SS Siddiqui, S Loganathan, S Krishnaswamy, L Faoro, R Jagadeeswaran, ...
Cancer biology & therapy 7 (6), 856-863, 2008
|Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease|
R Jagadeeswaran, BA Vazquez, M Thiruppathi, BB Ganesh, V Ibanez, ...
Experimental hematology 50, 46-52, 2017
|RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model|
A Rivers, K Vaitkus, MA Ruiz, V Ibanez, R Jagadeeswaran, ...
Experimental hematology 43 (7), 546-553. e3, 2015